Concepedia

Richard Wetzold

RW

Statistics

Publications

6

Citations

639

H-Index

6

Active since

2021

Affiliations

Imperial College Healthcare NHS Trust(Current)

Université Laval

University of Auckland

King Saud bin Abdulaziz University for Health Sciences

Intensive Care National Audit & Research Centre

Richard Wetzold is an author at Imperial College Healthcare NHS Trust specializing in medicine, pharmacotherapy, and acute care medicine.

Publications per year

2021–2023

6

Publications

6

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 151 citations · Full text

, , +15

Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial

Andreas Meiser, Norbert Weiler, Richard Wetzold · The Lancet Respiratory Medicine · 2021 · 138 citations

, , +16

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 137 citations · Full text

, , +6

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Yaseen M. Arabi, Anthony Gordon, Lennie Derde et al. · Intensive Care Medicine · 2021 · 100 citations · Full text

, , +9

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19

Simin Aysel Florescu, Mihaela Zaharia, Alma Kosa et al. · JAMA · 2023 · 67 citations · Full text

, , +7

1–5 of 6